ChromaDex

CDXC85

High Growth

$7.51arrow_drop_up0.19%$0.01

High Growth

CDXC85

$7.51

arrow_drop_up0.19%$0.01

High Growth

Performance History

Key Stats
Open	$7.52
Prev. Close	$7.52
EPS	0.02
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

	LOW	HIGH
Day Range	7.27	7.66
52 Week Range	1.25	7.66

Ratios







EPS	0.02

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About ChromaDex (CDXC)

ChromaDex Corp (CDXC) is a leading provider of proprietary, science-based ingredients and products to the dietary supplement, food and beverage, and cosmetic industries. The company's mission is to optimize human health and well-being through its innovative products. CDXC has a strong focus on research and development, investing significant resources into scientific studies to support the efficacy and safety of its ingredients. The company's flagship ingredient, NIAGEN®, is a patented form of nicotinamide riboside, a precursor to nicotinamide adenine dinucleotide (NAD+), which plays a critical role in cellular energy production and metabolism.

In addition to NIAGEN®, ChromaDex offers a range of other proprietary ingredients, including patented forms of pterostilbene and resveratrol, which are known for their antioxidant and anti-inflammatory properties. These ingredients have gained significant attention in the wellness industry for their potential health benefits. CDXC's products are supported by a robust portfolio of intellectual property, with over 30 issued and pending patents protecting its formulations and manufacturing processes.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Robert N. Fried
Headquarters: Los Angeles
Employees: 113
Exchange: NASDAQ

Keep an eye on ChromaDex

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is ChromaDex's (CDXC) price per share?

The current price per share for ChromaDex (CDXC) is $7.51. The stock has seen a price change of $0.01 recently, indicating a 0.2% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for ChromaDex (CDXC)?

For ChromaDex (CDXC), the 52-week high is $7.67, which is 2.05% from the current price. The 52-week low is $1.25, the current price is 501.2% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is ChromaDex (CDXC) a growth stock?

ChromaDex (CDXC) has shown an average price growth of -7.34% over the past three years. It has received a score of 93 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying ChromaDex as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is ChromaDex (CDXC) stock price performance year to date (YTD)?

As of the latest data, ChromaDex (CDXC) has a year-to-date price change of 425.52%. Over the past month, the stock has experienced a price change of 117.2%. Over the last three months, the change has been 125%. Over the past six months, the figure is 137.82%. Looking at a longer horizon, the five-year price change stands at 99.87%.

help

Is ChromaDex (CDXC) a profitable company?

ChromaDex (CDXC) has a net income of -$4.94M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 60.76% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 6.26% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $83.57M, with a revenue growth rate of 15.99%, providing insight into the company's sales performance and growth. The gross profit is $50.78M. Operating income is noted at -$5.6M. Furthermore, the EBITDA is $1.29M.

help

What is the market capitalization of ChromaDex (CDXC)?

ChromaDex (CDXC) has a market capitalization of $566.54M. The average daily trading volume is 7.58, indicating the stock's liquidity and investor engagement.